Prenatal Screening Tests: NIPT, Quad Screen and Next Steps

Prenatal Screening Tests: NIPT, Quad Screen and Next Steps

The rest of this page explains what each blood marker measures, why a screen positive result needs confirmation, where ultrasound fits in, and what screening cannot see at all.

Why is Down syndrome screening offered during pregnancy?

Screening is offered because trisomy 21 arises when an extra copy of chromosome 21 ends up in the cells of the developing pregnancy, a chance event during cell division that can occur in any pregnancy and that nothing a parent did causes.

People arrive at this conversation from several different directions. Some are offered screening as a standard part of routine prenatal care. Others ask about it because of a family history of a chromosome condition, a previous pregnancy affected by one, a finding on an early ultrasound, or age at conception, which is one of the factors a clinician weighs when discussing options. Screening is a choice rather than an obligation, and declining it is also a choice your care team should support.

The purpose of screening is to sort pregnancies into lower chance and higher chance groups so that further assessment can be offered where it is wanted. Identifying a pregnancy with an increased chance of a chromosome condition may help the care team arrange specialist review and plan further assessment 1.

What is the difference between a screening test and a diagnostic test?

A screening test gives a probability, while a diagnostic test examines the chromosomes themselves and gives an answer about them. That difference is the single most useful thing to hold on to when a result arrives.

Blood based screening measures signals that come from the placenta and the pregnancy, then combines them with details such as gestational dating to produce a chance figure. Cell-free DNA analysis is a screening test rather than a diagnostic one, even though it performs strongly for the common trisomies 2. Diagnostic testing means chorionic villus sampling or amniocentesis, where a specialist collects a sample of placental tissue or amniotic fluid so that fetal chromosomes can be examined directly. These procedures carry a small procedure related risk that your OB, midwife or a maternal fetal medicine specialist will describe in detail before you decide.

A screening result never says that a pregnancy has or does not have a chromosome condition. A value or chance figure outside the range printed on your lab report is worth discussing promptly with your OB or midwife, who decides what it reflects and what, if anything, comes next.

Which blood markers are used in Down syndrome screening?

Five serum markers and one DNA based measurement do most of the work, and each one is interpreted only as part of a combination. The table below sets out what each marker contributes and where its limits sit.

Marker Why it is used in screening What a result can and cannot tell you
Cell-free DNA (NIPT) Short DNA fragments released by the placenta circulate in the mother's blood and carry the chromosome 21 signal Can give a high chance or low chance estimate; cannot confirm a chromosome condition, and can return no result at all
PAPP-A (pregnancy associated plasma protein A) A placental protein measured in first trimester combined screening Feeds into a calculated chance figure; a single value read on its own says very little
hCG (total or free beta) A placental hormone used in both first and second trimester serum screens Only meaningful inside the risk calculation, and sensitive to how accurately the pregnancy is dated
AFP (alpha-fetoprotein) Made by the fetus and used in the second trimester screen, including for open neural tube defects Can flag a pregnancy for a detailed scan; cannot locate or confirm any structural difference
Unconjugated estriol Reflects placental and fetal contributions to estrogen production Interpreted only as one of the four quad screen markers
Inhibin A A placental hormone added to the older triple screen to create the quad screen Improves the combined estimate; not interpretable in isolation
Fetal fraction The share of cell-free DNA in the sample that came from the placenta A quality measure for the test itself; a low value points to a failed or inconclusive report rather than a reassuring one

Pregnancy shifts many laboratory values, so the numbers from a general health panel do not apply here. Serum screening markers are read as printed on your lab report, alongside gestational dating and pregnancy details, by your OB or midwife.

Can a blood test screen for Down syndrome before birth?

Yes, a maternal blood sample can be used to screen for trisomy 21 without any procedure that touches the pregnancy. During pregnancy, short cell-free DNA fragments originating from the placenta circulate in the mother's bloodstream, and laboratories count and compare these fragments to estimate the chance that an extra copy of chromosome 21 is present 3.

Research suggests that cell-free DNA screening has a high detection rate for trisomy 21 and a low false positive rate when it is built into antenatal screening programmes 4. The same approach is applied to a small number of other chromosome conditions and, in some laboratories, to selected single gene conditions 2.

Low does not mean zero, and high does not mean certain. A high chance result is described as screen positive, and it is the starting point for a conversation about diagnostic confirmation, not the end of one. Several features of a pregnancy can move the result in ways that have nothing to do with the fetus, including twin pregnancies, a twin that stopped developing early, chromosome differences confined to the placenta, and some maternal factors 5.

What does the quad screen measure?

The quad screen measures four substances in a second trimester maternal blood sample, AFP, hCG, unconjugated estriol and inhibin A, and combines them with gestational age and other details to produce chance figures for trisomy 21, trisomy 18 and open neural tube defects.

It remains in use where cell-free DNA screening is not available, not covered, or not chosen. Its strength is that one blood draw covers both chromosome screening and open neural tube defect screening. Its limit is that all four markers shift across pregnancy, so an error in dating changes the calculated chance even when every measured value is correct. This is one reason the calculation is left to the laboratory and the clinician rather than read off the report by eye.

A quad screen result is reported as a chance, for example one in a given number of pregnancies, rather than as a yes or a no. Your OB or midwife explains where the cut point used by that laboratory sits and what a result above or below it means for the options in front of you.

What do the first trimester markers add?

First trimester combined screening pairs two blood markers, PAPP-A and hCG, with a nuchal translucency measurement taken on ultrasound, and merges the three into a single chance figure.

The ultrasound component matters because it adds information no blood test carries, a direct look at the pregnancy at that stage. The blood component matters because placental proteins shift in some affected pregnancies. Neither part stands alone, and the combination is what the laboratory reports.

Can prenatal screening pick up spina bifida?

Cell-free DNA screening does not look for spina bifida, because it reads chromosome dosage rather than how the body has formed. Open neural tube defects, including spina bifida, are screened for in two other ways.

The first is AFP in the second trimester maternal blood sample, which is part of the quad screen. The second, and the one that looks at the spine directly, is the detailed anatomy ultrasound performed by a trained sonographer. An AFP value outside the range printed on the report is a reason for your OB or midwife to arrange further imaging and specialist review, not a finding that stands on its own.

If you choose cell-free DNA screening instead of a serum screen, ask your OB or midwife how open neural tube defect screening is being covered in your care, since the two tests answer different questions.

What does fetal fraction mean on an NIPT report?

Fetal fraction is the proportion of the cell-free DNA in the sample that came from the placenta rather than from the mother, and it determines whether the laboratory can report a result at all.

A low fetal fraction is associated with an inconclusive or failed cell-free DNA result, which is reported as no call rather than as a low chance 5. Sampling earlier in pregnancy, higher maternal weight and technical factors in the laboratory can all contribute. A no call is not a negative result and should not be read as one. The next step, whether that is a repeat blood draw, a different screening approach or a referral, is decided by your OB or midwife.

What happens when results do not agree?

When a cell-free DNA screen points one way and a diagnostic test points another, the diagnostic test is the one that examines fetal chromosomes, and the screening result is set aside.

Studies suggest that discordant results between cell-free DNA screening and diagnostic testing do occur, which is the reason a screen positive result is confirmed before any conclusion is drawn 6. Recognised contributors to a discordant or aberrant result include chromosome differences confined to the placenta, a vanishing twin, chromosome variation in the mother herself, and certain maternal health conditions 5.

This is also why a screening report should never be the basis for a decision on its own. Confirmation through chorionic villus sampling or amniocentesis, arranged and explained by a specialist, is the step that resolves the question.

How long do NIPT results take, and when is the test done?

Turnaround varies by laboratory, by the type of analysis ordered, and by whether a repeat sample is needed after a no call, so the only reliable answer is the current turnaround quoted by the laboratory running your sample. Ask the clinician who orders the test rather than planning around a figure found online.

Timing within pregnancy is set by your OB or midwife, because the test depends on enough placental cell-free DNA being present in the maternal circulation for the laboratory to analyse. Serum screens have their own timing, since the markers they measure change across pregnancy. If a sample is drawn too early for the method used, the likely outcome is a request to repeat the draw.

What does genetic counseling involve?

Genetic counseling is a conversation with a trained counsellor or clinician about what a test can and cannot answer, what a chance figure means for you, and what you would do with each possible result.

It covers family history, the difference between screening and diagnostic options, the chance of a no call, and the support available whatever the outcome. Research suggests that the information given before testing shapes how people experience the results and the decisions that follow 7. Counseling is offered before testing as well as after a screen positive result, and asking for it early is reasonable.

What can a normal panel still miss?

A low chance screening result covers a short list of conditions and says nothing about the rest. That is the honest limit of every prenatal screening test currently in routine use.

Several things sit outside its reach. Cell-free DNA screening and serum screens are built around a handful of chromosome conditions, so most single gene conditions, structural differences in the heart, limbs or abdominal wall, and conditions that arise later in pregnancy are not part of what they assess. Work on broadening what non-invasive prenatal screening can look for continues, and the scope of these tests is wider now than when cell-free DNA screening first entered practice 8. Even so, a wider screen is still a screen.

False negative results happen as well, which is why a low chance report does not remove the value of the anatomy ultrasound or of raising new symptoms with your care team. A screening result describes one moment and one question, not the whole pregnancy.

When should you see a clinician quickly?

Some symptoms in pregnancy need emergency care straight away, regardless of what any screening test showed.

Call 911 or go to the emergency department for any of these.

Contact your OB, midwife or maternity unit the same day for these.

If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.

How can you check these markers?

Prenatal screening markers are ordered through pregnancy care, so the route to NIPT, a quad screen or a first trimester combined screen is your OB or midwife, who also arranges the ultrasound component and any referral for diagnostic testing or counseling.

General health biomarkers sit in a different lane. Thyroid markers, iron studies, metabolic markers and vitamin D are part of a broader picture of how a body is running, and in pregnancy any testing beyond the standard prenatal schedule should be agreed with your OB or midwife first, because pregnancy itself shifts many values. FitScript is a labs-first membership with 150+ biomarkers tested per year, and Atlas, its AI health advisor, explains each result in plain language, while a licensed provider decides on any treatment.

This page is educational and not medical advice. Discuss every result and any proposed treatment with your OB, midwife or another licensed clinician before acting on it.

For a list of the general health markers covered outside pregnancy specific screening, see the FitScript Essential panel page.

Key takeaways

References

  1. Implications of non-invasive prenatal testing for identifying and managing high-risk pregnancies. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2021.
  2. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders. Best Practice & Research. Clinical Obstetrics & Gynaecology, 2017.
  3. Non-invasive prenatal testing using cell-free fetal DNA in maternal circulation. Clinica Chimica Acta, 2014.
  4. The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis. PLoS One, 2024.
  5. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review. Taiwanese Journal of Obstetrics & Gynecology, 2020.
  6. Discordant non-invasive prenatal testing (NIPT) - a systematic review. Prenatal Diagnosis, 2017.
  7. Psychological and social consequences of non-invasive prenatal testing (NIPT): a scoping review. BMC Pregnancy and Childbirth, 2019.
  8. Expanding the scope of non-invasive prenatal screening. Nature Genetics, 2025.

Common questions

How long do NIPT results take?

Turnaround depends on the laboratory running the sample, the analysis ordered, and whether a repeat blood draw is needed. Ask the clinician who ordered the test for that laboratory's current turnaround rather than relying on a general figure. If the report comes back as no call, your OB or midwife decides the next step.

What is the quad screen?

The quad screen is a second trimester maternal blood test measuring four substances, AFP, hCG, unconjugated estriol and inhibin A. The laboratory combines them with gestational dating to calculate a chance figure for trisomy 21, trisomy 18 and open neural tube defects. It gives a probability, never a confirmed answer.

When is NIPT done?

Your OB or midwife sets the timing, because the test needs enough placental cell-free DNA present in the maternal bloodstream for the laboratory to analyse. A sample drawn before there is enough of it is likely to come back without a result, which means repeating the draw. Ask your care team what timing applies to you.

Is NIPT a diagnostic test for Down syndrome?

No. NIPT is a screening test that produces a high chance or low chance estimate from a maternal blood sample. Only chorionic villus sampling or amniocentesis examines fetal chromosomes directly and answers the question. A high chance NIPT report is a reason to discuss diagnostic testing with your OB, midwife or a specialist.

What does a screen positive result mean?

A screen positive result means the calculated chance sits above the cut point that laboratory uses, so further discussion is offered. It is not a finding about the pregnancy on its own. The next step is a conversation with your OB, midwife or a genetic counsellor about confirmation through diagnostic testing.

Can prenatal screening detect spina bifida?

Cell-free DNA screening does not look for spina bifida, because it reads chromosome dosage rather than how the body has formed. Open neural tube defects are screened for through the AFP marker in the second trimester blood test and through the detailed anatomy ultrasound, which looks at the spine directly.

Who should have genetic counseling?

Genetic counseling is available to anyone considering prenatal screening, and it is offered after a screen positive or inconclusive result. A counsellor explains what each test can and cannot answer, reviews family history, and helps you decide what you want to know. You can ask for a referral before any sample is taken.

Do I have to have prenatal screening?

No. Prenatal screening is offered as a choice, and declining it is a decision your care team should support without pressure. Some people want the information, others do not, and both positions are reasonable. Discuss the options with your OB or midwife so the decision is yours and fully informed.

Related reading